Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-054624
Filing Date
2019-10-31
Accepted
2019-10-31 16:19:45
Documents
1
Period of Report
2019-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5727
  Complete submission text file 0001209191-19-054624.txt   7099
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address
BARRIS PETER J (Reporting) CIK: 0001005561 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39112 | Film No.: 191183878

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)